论文部分内容阅读
清解静脉注射液是在治疗“流脑”有效药——复方连翘静脉注射液研究的基础上,进行复方药物筛减研制成功的。它由银花,连翘,板兰根,小蘖碱及勾蘑碱组方,此制剂各种指标皆优于尻复方连翘注射液,从而为临床和生产提供了效果好(经临床扩大病种初步验证),毒性小,生产工艺及质量稳定的抗感染中药复方静脉用制剂,也为进行中药复方的研究积累了资料,摸索了方法和途径。
Qingxie intravenous injection was based on the research of “True brain” effective drug - Compound Forsythia intravenous injection, and compound drug screening was successfully developed. It consists of Yinhua, Forsythia, Banlangen, berberine and konulin base prescription. This preparation is superior to wolfberry compound forsythia injection in terms of various indicators, thus providing a good effect for clinical and production (clinical expansion disease) The initial verification), the toxicity of small, stable production technology and quality of anti-infective compound intravenous compound preparations, but also for the study of traditional Chinese medicine compound accumulation of data, explored methods and approaches.